Posts tagged Jefferies


Is It Premature to Celebrate Gilead Sciences, Inc.’s (GILD) Kite Pharma Momentum? Jefferies Looks Beyond the Recent Bull Rally

Analyst questions the bigger picture for GILD, including risks and visibility challenges wavering in 2018.

Read more

Top Analyst’s Internet Stock Picks: Facebook Inc (FB) and Amazon.com, Inc. (AMZN)

Here’s Why Facebook and Amazon Are Long-Term Winners of the Wall Street Horse Race

Read more

Will Trade Desk Inc (TTD) Momentum Continue? Top Analyst Says Yes

Trade Desk Inc (NASDAQ:TTD) stock is ticking upward today, after the digital ad firm delivered …

Read more

Jefferies Sees Strong Upside in AcelRx Pharmaceuticals’ Shares and Set a $7 Price Target

In a research report issued Friday, Jefferies analyst Matthew Andrews assumed coverage on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), …

Read more

Snap Inc (SNAP) Poised for Upside Ahead of 1st Quarter as a Public Company

Jefferies analyst Brian Fitzgerald is out with a confident research note evaluating Snap Inc (NYSE:SNAP) today, …

Read more

What to Expect from Gilead Sciences, Inc. (GILD) Amid M&A Buzz and Upcoming Catalysts

Analysts see an interesting path ahead for Gilead Sciences, Inc. (NASDAQ:GILD), between exciting collaborative possibilities …

Read more

Jefferies’ Brian Fitzgerald Reacts To Facebook Inc (FB) And Shutterfly, Inc. (SFLY) 4Q Prints

Jefferies analyst Brian Fitzgerald is joining the earnings conversation with mixed takes on Facebook Inc …

Read more

Jefferies’ Earnings Preview: Facebook Inc (FB), Amazon.com, Inc. (AMZN), Alphabet Inc (GOOGL)

Previewing fourth-quarter earnings, Jefferies analyst Brian Fitzgerald is setting confident expectations on the following large-cap internet …

Read more

Jefferies Says Buy Alphabet Inc (GOOGL); Here’s Why

Jefferies analyst Brian Fitzgerald has reiterated his Buy rating for Alphabet Inc (NASDAQ:GOOGL) following yesterday’s …

Read more

Hold Your Horses: Healthcare Analysts Cautious on Valeant Pharmaceuticals Intl Inc (VRX), Sarepta Therapeutics Inc (SRPT)

Valeant Pharmaceuticals Intl Inc Wells Fargo analyst David Maris weighs in on shares of Valeant Pharmaceuticals …

Read more